BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27648520)

  • 1. Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening.
    Whitley EM; Raich PC; Dudley DJ; Freund KM; Paskett ED; Patierno SR; Simon M; Warren-Mears V; Snyder FR;
    Cancer; 2017 Jan; 123(2):312-318. PubMed ID: 27648520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation.
    Ramachandran A; Freund KM; Bak SM; Heeren TC; Chen CA; Battaglia TA
    J Womens Health (Larchmt); 2015 Jan; 24(1):30-6. PubMed ID: 25513858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of patient navigation in eliminating economic disparities in cancer care.
    Rodday AM; Parsons SK; Snyder F; Simon MA; Llanos AA; Warren-Mears V; Dudley D; Lee JH; Patierno SR; Markossian TW; Sanders M; Whitley EM; Freund KM
    Cancer; 2015 Nov; 121(22):4025-34. PubMed ID: 26348120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
    Ramachandran A; Snyder FR; Katz ML; Darnell JS; Dudley DJ; Patierno SR; Sanders MR; Valverde PA; Simon MA; Warren-Mears V; Battaglia TA;
    Cancer; 2015 Nov; 121(22):4016-24. PubMed ID: 26385420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program.
    Freund KM; Battaglia TA; Calhoun E; Darnell JS; Dudley DJ; Fiscella K; Hare ML; LaVerda N; Lee JH; Levine P; Murray DM; Patierno SR; Raich PC; Roetzheim RG; Simon M; Snyder FR; Warren-Mears V; Whitley EM; Winters P; Young GS; Paskett ED;
    J Natl Cancer Inst; 2014 Jun; 106(6):dju115. PubMed ID: 24938303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing Time to Diagnostic Resolution After an Abnormal Cancer Screening Exam in Older Adult Participants in the Ohio Patient Navigation Research Program.
    DeSalvo JM; Young GS; Krok-Schoen JL; Paskett ED
    J Aging Health; 2018 Sep; 30(8):1284-1304. PubMed ID: 28649914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests?
    Paskett ED; Katz ML; Post DM; Pennell ML; Young GS; Seiber EE; Harrop JP; DeGraffinreid CR; Tatum CM; Dean JA; Murray DM;
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1620-8. PubMed ID: 23045536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.
    Markossian TW; Darnell JS; Calhoun EA
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1691-700. PubMed ID: 23045544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population.
    Raich PC; Whitley EM; Thorland W; Valverde P; Fairclough D;
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1629-38. PubMed ID: 23045537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program.
    Bensink ME; Ramsey SD; Battaglia T; Fiscella K; Hurd TC; McKoy JM; Patierno SR; Raich PC; Seiber EE; Warren-Mears V; Whitley E; Paskett ED; Mandelblatt S;
    Cancer; 2014 Feb; 120(4):570-8. PubMed ID: 24166217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis.
    Battaglia TA; Darnell JS; Ko N; Snyder F; Paskett ED; Wells KJ; Whitley EM; Griggs JJ; Karnad A; Young H; Warren-Mears V; Simon MA; Calhoun E
    Breast Cancer Res Treat; 2016 Aug; 158(3):523-34. PubMed ID: 27432417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening.
    Battaglia TA; Bak SM; Heeren T; Chen CA; Kalish R; Tringale S; Taylor JO; Lottero B; Egan AP; Thakrar N; Freund KM
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1645-54. PubMed ID: 23045539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care.
    Katz ML; Young GS; Reiter PL; Battaglia TA; Wells KJ; Sanders M; Simon M; Dudley DJ; Patierno SR; Paskett ED
    Womens Health Issues; 2014; 24(1):e155-62. PubMed ID: 24439942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participants' barriers to diagnostic resolution and factors associated with needing patient navigation.
    Krok-Schoen JL; Brewer BM; Young GS; Weier RC; Tatum CM; DeGraffinreid CR; Paskett ED
    Cancer; 2015 Aug; 121(16):2757-64. PubMed ID: 25921981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
    Singh N; Singh PS; Aggarwal AN; Behera D
    Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
    Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
    Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASA grade and Charlson Comorbidity Index of spinal surgery patients: correlation with complications and societal costs.
    Whitmore RG; Stephen JH; Vernick C; Campbell PG; Yadla S; Ghobrial GM; Maltenfort MG; Ratliff JK
    Spine J; 2014 Jan; 14(1):31-8. PubMed ID: 23602377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Different Intensities of Patient Navigation After Abnormal Mammography.
    Glassgow AE; Molina Y; Kim S; Campbell RT; Darnell J; Calhoun EA
    Health Promot Pract; 2019 Nov; 20(6):914-921. PubMed ID: 29907079
    [No Abstract]   [Full Text] [Related]  

  • 19. Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study.
    Simon MA; Nonzee NJ; McKoy JM; Liu D; Luu TH; Byer P; Eklund EA; Richey EA; Wu Z; Dong X; Rademaker AW
    BMC Health Serv Res; 2013 Aug; 13():314. PubMed ID: 23947435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social service barriers delay care among women with abnormal cancer screening.
    Primeau SW; Freund KM; Ramachandran A; Bak SM; Heeren T; Chen CA; Morton S; Battaglia TA
    J Gen Intern Med; 2014 Jan; 29(1):169-75. PubMed ID: 24197626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.